BullBD Old Apps Site
Home
Favorites
Recently viewed Details Chart Today news Share news Top gainer Top Looser Upcoming events
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0 1 2 3 4 5 6 7 8 9 All
Bank Cement Ceramics Sector Corporate Bond Engineering Financial Institutions Food & Allied Fuel & Power IT Sector Insurance Jute Life Insurance Miscellaneous Mutual Funds Paper & Printing Pharmaceuticals & Chemicals Services & Real Estate Tannery Industries Telecommunication Textile Travel & Leisure All
  • Details
  • Chart
  • News

ACMELAB

All Eps Dividend Board Agm Q1 Q2 Q3

ACMELAB 21-Apr-2021

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 27 2021 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended on March 31, 2021.

ACMELAB 06-Apr-2021

Mrs. Jahanara Mizan Sinha, one of the Sponsor Directors of the Company, has further reported that she has completed her buying of 69,500 shares of the Company at prevailing market price through Stock Exchange as per declaration disseminated on 01.04.2021.

ACMELAB 01-Apr-2021

Mrs. Jahanara Mizan Sinha, one of the Sponsor Directors of the Company, has expressed her intention to buy 69,500 shares of the Company at prevailing market price (in the Public Market) through Stock Exchange (DSE) within April 29, 2021.

ACMELAB 23-Feb-2021

Mrs. Jahanara Mizan Sinha, one of the Sponsor Directors of the Company, has further reported that she has completed her buying of 42,000 shares of the Company at prevailing market price through Stock Exchange (DSE) as per declaration disseminated on 16.02.2021.

ACMELAB 23-Feb-2021

Ms. Tasneem Sinha, one of the Directors of the Company, has further reported that she has completed her buying of 14,000 shares of the Company at prevailing market price through Stock Exchange (DSE) as per declaration disseminated on 16.02.2021.

ACMELAB 16-Feb-2021

Mrs. Jahanara Mizan Sinha, one of the Sponsor Directors of the Company, has expressed her intention to buy 42,000 shares of the Company at prevailing market price (in the Public Market) through Stock Exchange (DSE) within next 30 working days.

ACMELAB 16-Feb-2021

Ms. Tasneem Sinha, one of the Directors of the Company, has expressed her intention to buy 14,000 shares of the Company at prevailing market price (in the Public Market) through Stock Exchange (DSE) within next 30 working days.

ACMELAB 27-Jan-2021

(Q2 Un-audited): EPS was Tk. 1.78 for October-December, 2020 as against Tk. 1.77 for October-December, 2019; EPS was Tk. 3.74 for July-December, 2020 as against Tk. 3.66 for July-December, 2019. NOCFPS was Tk. 5.75 for July-December, 2020 as against Tk. 1.98 for July-December, 2019. NAV per share was Tk. 91.28 as on December 31, 2020 and Tk. 90.00 as on June 30, 2020.

ACMELAB 25-Jan-2021

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 26, 2021 at 4:30 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended on December 31, 2020.

ACMELAB 21-Jan-2021

Ms. Tasneem Sinha, one of the Directors of the Company, has further reported that he has completed his buying of 13,500 shares of the Company at prevailing market price through Stock Exchange as per declaration disseminated on 07.01.2021.

Previous Next page